Pretreatment Risk Stratification Tools for Prostate Cancer-Moving from Good to Better, Toward the Best

Eur Urol. 2020 Feb;77(2):189-190. doi: 10.1016/j.eururo.2019.10.016. Epub 2019 Nov 3.

Author

Annika Herlemann¹

Affiliation

¹ Department of Urology, University of California, San Francisco, CA, USA; Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany. Electronic address: Annika.Herlemann@ucsf.edu.

PMID: 31694773
DOI: 10.1016/j.eururo.2019.10.016

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cohort Studies
Humans
Male
Prostatic Neoplasms*
Risk Assessment